This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Incyte Corp. rallied 4.1% to $59.22 on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index rising 0.8% to 5,405.97 and the Dow Jones Industrial Average rising 0.8% to 40,524.79.
This was the stock's second consecutive day of gains.
Incyte Corp. closed 29.5% below its 52-week high of $83.95, which the company achieved on November 8th.
The stock demonstrated a mixed performance when compared to some of its competitors, as Alnylam Pharmaceuticals Inc. rose 0.9% to $240.01, Bio-Techne Corp. rose 3.6% to $52.54, and BioMarin Pharmaceutical Inc. rose 5.02% to $59.67.
Trading volume totaled 2.0 million, compared to the 50-day average of 2.1 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
April 14, 2025 16:34 ET (20:34 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。